PATENT CLAIM ANALYSIS

Application Number: 15773454
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "364000"]

Abstract:
The present invention is directed to pharmaceutical compositions of an inhibitor of indoleamine 2,3-dioxygenase and are useful in the treatment of cancer and other disorders.

Claim (Index 49):
The method of any one of  claims 1  to  48 , wherein the cancer is colon cancer, pancreatic cancer, breast cancer, prostate cancer, lung cancer, brain cancer, ovarian cancer, cervical cancer, testicular cancer, renal cancer, head and neck cancer, lymphoma and leukemia.

Metadata:
- Claim Count in Document: 107.0
- Percentile: 93.0
- Lexical Diversity: 1.13043
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15093420', '16061597', '13294711', '14661191', '14033117']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7894485019427311
- 35 USC 102 Novelty (BERT): 0.5350854108231387
- Combined Prediction Score: 0.7640121928307718
- Mean Citation Score: 260.49462800000003
- Max Citation Score: 267.73694
- Similarity Product: 183.04580012305976

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test